Pillstats
Rx only · Tablet · Oral

Fluphenazine Hydrochloride

Fluphenazine Hydrochloride

5 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US15 NDCs
5 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)4496
US makers5 labelers
Packages21
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 10 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.120$0.241$0.361$0.481Dec 2025Apr 2026Jul 2026
$0.238
Latest avg · Jul 22, 2026
-43%
Since Dec 17, 2025
5
Active US suppliers
52%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

6.6K13K20K26K2025 Q12025 Q22025 Q32025 Q42026 Q1
18K
Rx · 2026 Q1
871K
Units dispensed
-11%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it5 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
ANI Pharmaceuticals, Inc.unknown6SUPPLYING
Aurobindo Pharma Limitedunknown5SUPPLYING
Marlex Pharmaceuticals Incunknown4SUPPLYING
Ajanta Pharma USA Inc.unknown4SUPPLYING
REMEDYREPACK INC.repackager2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.